A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer

被引:145
作者
Jeronimo, Jose [1 ]
Bansil, Pooja [1 ]
Lim, Jeanette [1 ]
Peck, Roger [1 ]
Paul, Proma [1 ]
Amador, Juan Jose [2 ]
Mirembe, Florence [3 ]
Byamugisha, Josaphat [4 ]
Poli, Usha Rani [5 ]
Satyanarayana, Labani
Asthana, Smita
机构
[1] PATH, Reprod Hlth Global Program, Seattle, WA 98121 USA
[2] PATH, Reprod Hlth Program, Kampala, Uganda
[3] Makerere Univ, Dept Obstet & Gynecol, Kampala, Uganda
[4] Mulago Hosp, Dept Obstet & Gynecol, Kampala, Uganda
[5] MNJ Canc Inst, Oncol & Reg Canc Ctr, Hyderabad, Andhra Pradesh, India
基金
比尔及梅琳达.盖茨基金会;
关键词
Cancer prevention and control; Early detection; Cervical cancer; Low-resource settings; HPV; HPV-DNA TEST; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT VACCINE; CLINICAL ACCURACY; RANDOMIZED-TRIAL; SCREENING TRIAL; YOUNG-WOMEN; PREVENTION; DISEASES;
D O I
10.1097/IGC.0000000000000084
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. Methods and Materials Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, visual inspection with acetic acid (VIA), and Papanicolaou test were evaluated among 16,951 eligible women in India, Nicaragua, and Uganda. Women with positive screening results received colposcopy and histologic follow-up as indicated. The positivity of each screening method was calculated overall, by site, and age. In addition, the clinical performance of each screening test was determined for detection of cervical intraepithelial neoplasia (CIN) grade 2 (CIN2+) and CIN grade 3. Results Moderate or severe dysplasia or cancer (taken together as CIN2+) was diagnosed in 286 women. The positivity rate ranged between 2.4% to 19.6% for vaginal careHPV, 2.9% to 20.2% for cervical careHPV, 5.5% to 34.4% for VIA, and 2.8% to 51.8% for Papanicolaou test. Cervical careHPV was the most sensitive for CIN2+ (81.5%; 95% confidence interval [CI], 76.5-85.8) and CIN grade 3 (85.3%; 95% CI, 78.6-90.6) at all sites, followed by vaginal careHPV (69.6% and 71.3%, respectively). The sensitivity of VIA ranged from 21.9% to 73.6% and Papanicolaou test from 40.7% to 73.7%. The pooled specificities of cervical careHPV, vaginal careHPV, VIA, and Papanicolaou test were 91.6%, 90.6%, 84.2%, and 87.7%, respectively. ConclusionscareHPV performed well in large multicountry demonstration studies conducted in resource-limited settings that have not previously been conducted this type of testing; its sensitivity using cervical samples or vaginal self-collected samples was better than VIA or Papanicolaou test. The feasibility of using careHPV in self-collected vaginal samples opens the possibility of increasing coverage and early detection in resource-constrained areas.
引用
收藏
页码:576 / 585
页数:10
相关论文
共 26 条
[1]  
[Anonymous], 2010, GLOBOCAN 2008 V1 2 C
[2]   Accuracy of Several Cervical Screening Strategies for Early Detection of Cervical Cancer A Meta-Analysis [J].
Chen, Changxian ;
Yang, Zhijun ;
Li, Zhuang ;
Li, Li .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (06) :908-921
[3]   Overview of the European and North American studies on HPV testing in primary cervical cancer screening [J].
Cuzick, Jack ;
Clavel, Christine ;
Petry, Karl-Ulrich ;
Meijer, Chris J. L. M. ;
Hoyer, Heike ;
Ratnam, Samuel ;
Szarewski, Anne ;
Birembaut, Philippe ;
Kulasingam, Shalini ;
Sasieni, Peter ;
Iftner, Thomas .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) :1095-1101
[4]   Human Papillomavirus-Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial [J].
Denny, Lynette ;
Kuhn, Louise ;
Hu, Chih-Chi ;
Tsai, Wei-Yann ;
Wright, Thomas C., Jr. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (20) :1557-1567
[5]   Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile [J].
Ferreccio, Catterina ;
Isabel Barriga, Maria ;
Lagos, Marcela ;
Ibanez, Carolina ;
Poggi, Helena ;
Gonzalez, Francisca ;
Terrazas, Solana ;
Katki, Hormuzd A. ;
Nunez, Felipe ;
Cartagena, Jaime ;
Van De Wyngard, Vanessa ;
Vinales, Daysi ;
Branes, Jorge .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (04) :916-923
[6]   Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases [J].
Garland, Suzanne M. ;
Hernandez-Avila, Mauricio ;
Wheeler, Cosette M. ;
Perez, Gonzalo ;
Harper, Diane M. ;
Leodolter, Sepp ;
Tang, Grace W. K. ;
Ferris, Daron G. ;
Steben, Marc ;
Bryan, Janine ;
Taddeo, Frank J. ;
Railkar, Radha ;
Esser, Mark T. ;
Sings, Heather L. ;
Nelson, Micki ;
Boslego, John ;
Sattler, Carlos ;
Barr, Eliav ;
Koutsky, Laura A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1928-1943
[7]   Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial [J].
Hildesheim, Allan ;
Herrero, Rolando ;
Wacholder, Sholom ;
Rodriguez, Ana C. ;
Solomon, Diane ;
Bratti, M. Concepcion ;
Schiller, John T. ;
Gonzalez, Paula ;
Dubin, Gary ;
Porras, Carolina ;
Jimenez, Silvia E. ;
Lowy, Douglas R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (07) :743-753
[8]  
IARC, 2021, CERV CANC SCREEN IAR
[9]   Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial [J].
Lehtinen, Matti ;
Paavonen, Jorma ;
Wheeler, Cosette M. ;
Jaisamrarn, Unnop ;
Garland, Suzanne M. ;
Castellsague, Xavier ;
Skinner, S. Rachel ;
Apter, Dan ;
Naud, Paulo ;
Salmeron, Jorge ;
Chow, Song-Nan ;
Kitchener, Henry ;
Teixeira, Julio C. ;
Hedrick, James ;
Limson, Genara ;
Szarewski, Anne ;
Romanowski, Barbara ;
Aoki, Fred Y. ;
Schwarz, Tino F. ;
Poppe, Willy A. J. ;
De Carvalho, Newton S. ;
Germar, Maria Julieta V. ;
Peters, Klaus ;
Mindel, Adrian ;
De Sutter, Philippe ;
Xavier Bosch, F. ;
David, Marie-Pierre ;
Descamps, Dominique ;
Struyf, Frank ;
Dubin, Gary .
LANCET ONCOLOGY, 2012, 13 (01) :89-99
[10]   International correlation between human papillomavirus prevalence and cervical cancer incidence [J].
Maucort-Boulch, Delphine ;
Franceschi, Silvia ;
Plummer, Marlyn .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (03) :717-720